A watered-down Covid-19 vaccine IP waiver nears the finish line: Will it actually expand supplies?
The US, EU, India, and South Africa have forged at least a preliminary agreement around an intellectual property (IP) waiver at the World Trade Organization — a move the four countries hope will help others attain more Covid-19 vaccine supplies, even as advocates have said the waiver won’t do much.
The waiver, according to a leaked draft version, will apply to any developing country participating in the WTO that exported less than 10% of the world’s Covid-19 vaccine doses in 2021 (i.e., not China or Russia, but India could use it).
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.